[HTML][HTML] Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology
B Owens - The Lancet Rheumatology, 2020 - thelancet.com
Excitement about a potential new treatment for the coronavirus disease 2019 (COVID-19)
pandemic currently engulfing the world is causing problems for patients with arthritis and
systemic lupus erythematosus (SLE), who routinely use the drug to control their
symptoms.The antimalarial drug chloroquine and its safer derivative hydroxychloroquine
have been used since the 1940s to treat autoimmune disorders, says Thomas Dörner, a
rheumatologist at the Charité University Hospital in Berlin. Though the drug is rarely used for …
pandemic currently engulfing the world is causing problems for patients with arthritis and
systemic lupus erythematosus (SLE), who routinely use the drug to control their
symptoms.The antimalarial drug chloroquine and its safer derivative hydroxychloroquine
have been used since the 1940s to treat autoimmune disorders, says Thomas Dörner, a
rheumatologist at the Charité University Hospital in Berlin. Though the drug is rarely used for …